myrtenal has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alexandrova, A; Bibi, A; Dragomanova, S; Georgieva, A; Kalfin, R; Lazarova, M; Munkuev, A; Reynisson, J; Salakhutdinov, N; Stefanova, M; Suslov, E; Tancheva, L; Tzvetanova, E; Uzunova, D; Volcho, K | 1 |
| Dogra, AK; Kaufmann, D; Wink, M | 1 |
2 other study(ies) available for myrtenal and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
New Myrtenal-Adamantane Conjugates Alleviate Alzheimer's-Type Dementia in Rat Model.
Topics: Acetylcholinesterase; Adamantane; Alzheimer Disease; Animals; Antioxidants; Bicyclic Monoterpenes; Maze Learning; Neurodegenerative Diseases; Neuroprotective Agents; Norepinephrine; Oxidative Stress; Rats; Rats, Wistar; Scopolamine; Serotonin | 2022 |
Myrtenal inhibits acetylcholinesterase, a known Alzheimer target.
Topics: Acetylcholinesterase; Alzheimer Disease; Bicyclic Monoterpenes; Cholinesterase Inhibitors; Colorimetry; Cyclohexanols; Cymenes; Enzyme Inhibitors; Eucalyptol; Humans; Monoterpenes; Oils, Volatile; Phytotherapy; Plant Extracts; Terpenes | 2011 |